- Issuer ticker
-
BIIB
- Reported as of
-
06 Feb 2026
- Net transaction value
-
-$410,005
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
10 Feb 2026, 17:00:19 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Wendell Taylor, attorney-in-fact for Rachid Izzar
Key filing fact
Rachid Izzar filed Form 4 for BIOGEN INC. (BIIB) on 10 Feb 2026.
Key facts
- This page summarizes Rachid Izzar's Form 4 filing for BIOGEN INC. (BIIB).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 10 Feb 2026, 17:00.
Change
- Previous filing in this sequence was filed on 16 Jul 2025.
- Current net transaction value: -$410,005.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001875506
Primary reporting owner
Izzar Rachid
- Relationship
-
Head of Global Product Strat.
- Address
- 225 BINNEY STREET, CAMBRIDGE
- Signature
- /s/ Wendell Taylor, attorney-in-fact for Rachid Izzar
- Signature date
- 10 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,044
- Change %
- +33%
- Price
-
$0.000000
- Shares after
- 8,204
- Date
- 06 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
BIIB
transaction
Common Stock
Tax liability
- Transaction value
- $161,950
- Shares
- -805
- Change %
- -9.8%
- Price
-
$201.18
- Shares after
- 7,399
- Date
- 06 Feb 2026
- Ownership
- Direct
BIIB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,802
- Change %
- +24%
- Price
-
$0.000000
- Shares after
- 9,201
- Date
- 06 Feb 2026
- Ownership
- Direct
BIIB
transaction
Common Stock
Tax liability
- Transaction value
- $92,140
- Shares
- -458
- Change %
- -5%
- Price
-
$201.18
- Shares after
- 8,743
- Date
- 06 Feb 2026
- Ownership
- Direct
BIIB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +3,043
- Change %
- +35%
- Price
-
$0.000000
- Shares after
- 11,786
- Date
- 06 Feb 2026
- Ownership
- Direct
BIIB
transaction
Common Stock
Tax liability
- Transaction value
- $155,914
- Shares
- -775
- Change %
- -6.6%
- Price
-
$201.18
- Shares after
- 11,011
- Date
- 06 Feb 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIIB
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -2,044
- Change %
- -100%
- Price
-
$0.000000
- Shares after
- 0
- Date
- 06 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,044
- Exercise price
- $0.000000
- Footnotes
- F2
BIIB
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -1,802
- Change %
- -50%
- Price
-
$0.000000
- Shares after
- 1,802
- Date
- 06 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,802
- Exercise price
- $0.000000
- Footnotes
- F3
BIIB
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -3,043
- Change %
- -33%
- Price
-
$0.000000
- Shares after
- 6,087
- Date
- 06 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,043
- Exercise price
- $0.000000
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Explanation of responses
4 footnotes